|1.||Tylko, Grzegorz: 1 article (08/2010)|
|2.||Windak, Renata: 1 article (08/2010)|
|3.||Styrna, Józefa: 1 article (08/2010)|
|4.||Kowal, Małgorzata: 1 article (08/2010)|
|5.||Lenartowicz, Małgorzata: 1 article (08/2010)|
08/01/1993 - "The results indicate that Cu-ATP does not adversely affect hematopoiesis while it inhibits tumor growth; on the contrary, it has a stimulatory effect on murine granulocytopoiesis."
02/01/1994 - "Glutaminase-Cu-ATP combination (glutaminase 250 IU/kg per day intraperitoneally for 10 days and Cu-ATP 2.5 mg/kg per day intraperitoneally for 10 days) was observed to be more effective in inhibiting tumor growth and in increasing the life span of the tumor hosts, compared with the individual efficacies of these two agents. "
02/01/1994 - "Thus glutaminase in combination with Cu-ATP holds promise for an effective cancer chemotherapeutic regimen."
06/14/1991 - "Studies of the response of liver glutaminase after Cu-ATP treatment reveals that Cu-ATP is capable of reducing the high glutaminase level in subjects with malignant tumors to the normal level."
02/01/1994 - "Moreover, addition of Cu-ATP successfully prevented the hematotoxic effects of glutaminase in normal and in tumor-bearing animals. "
|2.||Menkes Kinky Hair Syndrome (Menkes Disease)
|3.||Adenosine Triphosphate (ATP)